Services
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
Disease Models
Efficacy studies of lead candidates in animal disease models are vital for preclinical candidate selection in drug discovery. The relevant disease models and DMPK assays are used to study the biological effects of drug candidates. Creative Bioarray has established multiple animal disease models including cardiovascular disease models, chronic liver disease models, metabolic disease models, neurological disease models, oncology models, etc. We provide validated and custom in vivo disease modeling and services. Our comprehensive animal-based disease models of different organ systems allow our clients to choose the most appropriate models to test promising compounds and optimize lead candidates.
Available in vivo disease models:
Oncology Models
- Cell line-derived xenograft models (CDX)
- Patient-derived xenograft models (PDX)
- Syngeneic and orthotopic models
- Gene-edited animal models
- Chemically induced animal models
Neurological Disease Models
- Alzheimer's disease
- Seizure
- Parkinson's disease
- Ischemic Stroke Model
- Acute Spinal Cord Injury (ASCI) Model
- Traumatic Brain Injury (TBI) Model
- Hypoxic-Ischemic Encephalopathy (HIE) Model
- Tourette Syndrome (TS) Model
- Amyotrophic Lateral Sclerosis (ALS) Model
- Huntington’s Disease Model
- Intracerebral Hemorrhage (ICH) Models
Gastrointestinal Disease Models
Cardiovascular Disease Models
- Surgical models
- Animal models of hypertension
- DOCA-salt model
- Spontaneously hypertensive rat model
- Two-kidney-one-clip (2K1C) renovascular hypertension model
- Venous thrombosis model
- Atherosclerosis model
- Cardiac arrhythmia model
- Hyperlipoidemia model
- Drug-induced heart failure model
- Arterial Thrombosis Model
- Pulmonary Arterial Hypertension (PAH) Model
Liver Disease Models
- Alcoholic liver disease model
- Liver fibrosis model
- Acute liver injury
- Chronic liver injury
- Chronic fatty liver disease
- Alcoholic steatohepatitis (ASH) & non-Alcoholic steatohepatitis (NASH)
Metabolic Disease Models
- Type 1 diabetes mellitus model
- Type 2 diabetes mellitus model
- Animal model of hyperuricemia
- Nonalcoholic fatty liver disease (NASH) model
- High fat diet-induced obesity model
- Dyslipidemia
- Obesity
- Organ damage (UUO, CKD)
Respiratory Disease Models
Ocular Disease Models
- Inflammatory disorders
- Eye irritation
- Retinopathy of prematury
- Stromal ulceration
- Corneal graft
- Infectious keratitis
- Diabetic retinopathy
Inflammation & Autoimmune Disease Models
- Rheumatoid arthritis models
- Nephritis models
- Multiple sclerosis (MS) models
- Ocular inflammation models
- Sjögren's syndrome model
- LPS-induced acute lung injury model
- Peritonitis models
- Passive cutaneous anaphylaxis model
- Delayed-type hypersensitivity models
- Inflammatory bowel disease models
- Systemic lupus erythematosus animal models
- Oral mucositis model
- Asthma model
- Sepsis model
- Psoriasis model
- Atopic dermatitis (AD) model
- Scleroderma model
- Gouty arthritis model
- Carrageenan-Induced Air Pouch Synovitis Model
- Carrageenan-Induced Paw Edema Model
- Experimental Autoimmune Myasthenia Gravis (EAMG) Model
- Graft-versus-host Disease (GvHD) Model
Orthopedic Disease Models
Urology Disease Models
Rare Disease Models
- Huntington's disease
- Amyotrophic lateral sclerosis (ALS)
- Batten disease
- Multiple sclerosis (MS)
- Systemic lupus erythematosus (SLE)
- Muscular dystrophy
Pain Models
Surgical Models
- Cisterna magna cannulation
- Bile duct cannulation
- Portal vein cannulation
- Thoracic duct cannulation
- Intraduodenally administration
Each of the above disease models is designed to understand specific aspects of drug property and its mechanism of action. Besides, the animals used for studies are provided by certified animal suppliers. All study protocols and animal use are approved by IACUC. By accessing our comprehensive capability, our customers can advance their drug discovery projects faster.
Contact us for more information on the listed disease models or if you would like to customize a new model to meet your particular needs. With all our In Vivo Services, we ensure continuous communications and discussions during on-going studies. Please feel free to contact us to find out more about our capabilities and services.
Explore Other Options
For research use only. Not for any other purpose.